FDA Inspection 1270644 — Beth Israel Deaconess Medical Center
The FDA completed an inspection of Beth Israel Deaconess Medical Center on April 30, 2025 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 30, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Boston, MA (United States)